PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
42.26%
Revenue growth above 1.5x TSM's 4.54%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
33.62%
Gross profit growth above 1.5x TSM's 4.54%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
37.12%
EBIT growth above 1.5x TSM's 4.54%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
37.12%
Operating income growth above 1.5x TSM's 4.54%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
33.01%
Net income growth above 1.5x TSM's 4.54%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
20.00%
EPS growth above 1.5x TSM's 4.04%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
25.00%
Diluted EPS growth above 1.5x TSM's 4.04%. David Dodd would see if there's a robust moat protecting these shareholder gains.
1.51%
Share change of 1.51% while TSM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-0.08%
Reduced diluted shares while TSM is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-66.51%
Negative OCF growth while TSM is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-105.20%
Negative FCF growth while TSM is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
212.15%
10Y revenue/share CAGR 1.25-1.5x TSM's 173.95%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
212.15%
5Y revenue/share CAGR 1.25-1.5x TSM's 173.95%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
212.15%
3Y revenue/share CAGR above 1.5x TSM's 71.79%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
51.59%
OCF/share CAGR of 51.59% while TSM is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
51.59%
OCF/share CAGR of 51.59% while TSM is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
51.59%
3Y OCF/share CAGR of 51.59% while TSM is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
244.57%
Positive 10Y CAGR while TSM is negative. John Neff might see a substantial advantage in bottom-line trajectory.
244.57%
Positive 5Y CAGR while TSM is negative. John Neff might view this as a strong mid-term relative advantage.
244.57%
Positive short-term CAGR while TSM is negative. John Neff would see a clear advantage in near-term profit trajectory.
407.50%
Equity/share CAGR of 407.50% while TSM is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
407.50%
Equity/share CAGR of 407.50% while TSM is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
407.50%
Equity/share CAGR of 407.50% while TSM is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.27%
AR growth of 4.27% while TSM is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
34.46%
Inventory growth of 34.46% while TSM is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
4.88%
Asset growth of 4.88% while TSM is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
14.02%
BV/share growth of 14.02% while TSM is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
1.72%
Debt growth of 1.72% while TSM is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
31.33%
R&D growth of 31.33% while TSM is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
25.17%
SG&A growth of 25.17% while TSM is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.